Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
-
-
-
Apr 15, 2013 Drugs effective against tumors, studies show Tags: aacr 2013, bind-014, daniel von hoff, scottsdale healthcare, tgen
Collaboration with noted neurologists to plan next clinical studies
Tags: alzheimers, banner, parkinson's, proteomics, sun health research institute[Source: PRNewswire-FirstCall] - Transgenomic, Inc. (OTCBulletinBoard: TBIO) and Power3 Medical Products, Inc. (OTCBulletinBoard: PWRM) , announced the clinical introduction of the NuroPro(R) AD and NuroPro(R) PD tests for Alzheimer's and Parkinson's disease at the 2009 American Academy of Neurology meeting in Seattle, WA. The NuroPro tests help clinicians distinguish patients with Alzheimer's and Parkinson's diseases from "normal" individuals and patients with other neurological disorders. The tests, developed by Power3, are a panel of blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability a patient has neurodegenerative disease. This information will help physicians make earlier diagnoses and recommend appropriate follow-up and treatment options for their patients.
For more information click here.
Quick Links
![]()
“A Bridge Crossed,” a brochure featuring the 2012 progress of Arizona’s Bioscience Roadmap, as well as "Performance Assessment 2002-12," featuring the latest bioscience sector data from Battelle Technology Partnership Practice, are now available.


Share on Twitter
Share on Facebook


